跳至主要内容
临床试验/EUCTR2010-020945-28-ES
EUCTR2010-020945-28-ES进行中(未招募)1 期

Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients.A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.//Estrategias antihipertensivas Perindopril arginina/Amlodipino versus Valsartan/Amlodipino: Eficacia y seguridad en pacientes hipertensos de leves a moderados.Estudio aleatorizado, doble ciego durante 6 meses y que se continúa con un seguimiento a largo plazo en abierto durante 8 meses con Perindopril arginina/Amlodipino

Itziar Fernandez Gonzalez0 个研究点目标入组 1,600 人开始时间: 2010年9月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Paientes ambulatorios,
  • - Homabres ó mujeres
  • - igual ó mayor de 18 años,
  • - paciente hipertenso de leve a moderado.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Mujeres embaradas ó en periodo de lactancia,
  • - Hipertensión secundaria,
  • - Caulquier paciente que sufra una enfermedad aguda ó crónica

研究者

发起方
Itziar Fernandez Gonzalez

相似试验

进行中(未招募)
不适用
S5985 combination versus Angiotensin II Receptor blocker/Calcium Channel Blocker: a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.1Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 100000004866
EUCTR2010-020945-28-PTInstitut de Recherches Internationales Servier1,600
尚未招募
3 期
Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive startegies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.arterial hypertensionhigh blood pressure10057166
NL-OMON34436Servier R&D Benelux50
进行中(未招募)
不适用
S 05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker : a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.0Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 10047065 - Vascular disorders
EUCTR2010-020945-28-LVInstitut de Recherches Internationales Servier1,600
进行中(未招募)
1 期
S 05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker : a comparison of blood pressure lowering - efficacy and safety
EUCTR2010-020945-28-GBInstitut de Recherches Internationales Servier1,600
进行中(未招募)
不适用
S05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker: a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.0Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 10047065 - Vascular disorders
EUCTR2010-020945-28-BEInstitut de Recherches Internationales Servier1,600